Loading...
  • grafts
  • Although the survival rates for these HLA-matched cord blood grafts appeared significant, the number of children studied was small, and further study is required to confirm this finding, the researchers said. (medpagetoday.com)
  • However, Dr. Wagner and his colleagues said, "in the absence of a randomized trial, we cannot definitively state the relative efficacy of bone-marrow and cord-blood grafts, but the data support the use of cord-blood grafts in children with acute leukemia. (medpagetoday.com)
  • Hematology
  • The NYOH medical staff includes 35 board certified physicians who specialize in the care of patients with cancer (medical oncology and radiation oncology) and blood-related disorders (hematology). (dana-farber.org)
  • Therapeutics
  • USOTC:MBLTY) today provided an update on its clinical programs using the product Prochymal®, which was acquired as part of the entire culture-expanded mesenchymal stem cell (MSC) business of Osiris Therapeutics (NASDAQ:OSIR) by the Mesoblast Group. (cnbc.com)
  • diseases
  • Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy," Clinical Infectious Diseases , vol. 53, no. 9, pp. 944-951, 2011. (hindawi.com)
  • 500 cells/ μ L in HIV type 1-infected individuals receiving potent antiretroviral therapy," Clinical Infectious Diseases , vol. 41, no. 3, pp. 361-372, 2005. (hindawi.com)
  • CBCI conducts cutting edge clinical research, testing innovative treatments for patients with blood cancers and bone marrow diseases. (dana-farber.org)
  • treatment
  • CBCI was developed to provide state-of-the-art treatment for blood cancers such as leukemia, lymphoma and multiple myeloma. (dana-farber.org)
  • A multidisciplinary team, including nurse navigators, provides personalized care in the 49-bed inpatient unit and outpatient Cancer and Therapeutic Blood Treatment Center. (dana-farber.org)
  • Due to the novelty, the treatment is being offered in the form of a clinical trial. (debra-international.org)
  • The marked advancement in animal models has stimulated the use of this treatment in clinical settings. (biomedcentral.com)
  • Last week, CryoSave released a cord blood stem cell unit from the state of the art laboratory in Geneva for the clinical treatment of a young boy who suffers from thalassemia major. (yahoo.com)
  • observations raise the possibility
  • These observations raise the possibility that cord blood may serve as a source of cells to facilitate tissue repair and regeneration in the future. (weltbild.de)
  • These novel scientific and clinical observations raise the possibility that T cell-related mechanisms may also be enhanced using ex vivo pharmacologic modulation strategies. (cnbc.com)
  • infusion
  • The subjects will be undertaken allogeneic umbilical cord blood infusion intravenously or intraarterially under non-myeloablative immunosuppression. (clinicaltrials.gov)
  • Laskowitz, Bennett, and colleagues conducted an open-label trial of this therapy in a group of 10 participants, finding that a single IV infusion therapy of this blood appears to be safe and that a phase-2 study is in order. (duke.edu)
  • survival
  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the swiss HIV cohort study," Lancet , vol. 356, no. 9244, pp. 1800-1805, 2000. (hindawi.com)
  • They fail to grow normally and are, in the severest cases, dependent on blood transfusions for survival, with the inherent risks and complications that this may bring. (yahoo.com)